Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
NCT ID: NCT01747369
Last Updated: 2017-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2010-04-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo
NCT04701996
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
NCT05060146
Study of the Impact of an Intervention Performed by a Clinical Pharmacist on Patients at Risk of Pneumococcal Infection at the End of Hospitalization
NCT04734925
Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia
NCT03996967
Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan
NCT00757575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalised in a study site during the study period
* resident of Tône sanitary district
* presenting clinical signs of acute bacterial meningitis
* hospitalised in a study site during the study period
Exclusion Criteria
Meningitis surveillance:
* absence of informed consent by patient or legal tutor
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Sanitaire des Savanes, Togo
UNKNOWN
Ministere de la Sante et de la Promotion Sociale, Togo
UNKNOWN
Institut National d'Hygiene, Togo
UNKNOWN
Centre Muraz
OTHER
Fondation Mérieux, France
UNKNOWN
Pfizer
INDUSTRY
Agence de Médecine Préventive, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer C Moïsi, PhD
Role: PRINCIPAL_INVESTIGATOR
Agence de Médecine Préventive
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Régional (CHR) Savanes
Dapaong, Savanes, Togo
Clinique Win' Pang
Dapaong, Savanes, Togo
Hôpital d'enfants Yendubé
Dapaong, Savanes, Togo
Polyclinique
Dapaong, Savanes, Togo
Centre médico-social (CMS)
Sinkassé, Savanes, Togo
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PneumoTone
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.